References
- Abell, C. W. and Kwan, S. W., Molecular characterization of monoamine oxidase A and B. Prog. Nucl. Acids Res. Mol. Biol., 65, 129-156 (2001) https://doi.org/10.1016/S0079-6603(00)65004-3
- Bach, A. W., Lan, N. C., Johnson, D. L., Abell, C. W., Bembenek, M. E., Kwan, S. W., Seeburg, P. H., and Shih, J. C., cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties. Proc. Natl. Acad. Sci. U.S.A., 85, 4934-4938 (1988) https://doi.org/10.1073/pnas.85.13.4934
- Benedetti, M. S. and Dostert, P., Monoamine oxidase: from physiology and pathophysiology to the design and clinical application of reversible inhibitors. In Testa, B. (Eds.) Advances in Drug Research, vol. 23. Academic Press, New York, pp.65-125 (1992)
- Jo, Y. S., Huong, D. T., Bae, K., Lee, M. K., and Kim, Y. H., Monoamine oxidase inhibitory coumarin from Zanthoxylum schinifolium. Planta Med., 68, 84-85 (2002) https://doi.org/10.1055/s-2002-20056
- Jung, B. S. and Shin, M. K., Encyclopedia of illustrated Korean natural drugs. Young Lim Sa, Seoul, pp707-708 (1989)
- Kalgutkar, A. S., Castagnoli, N. J., and Testa, B., Selective inhibitors of monoamine oxidase as probes of its catalytic site and mechanism. Med. Res. Rev., 4, 325-388 (1995) https://doi.org/10.1002/med.2610150406
- Kraml, M., A rapid microfluorimetric determination of monoamine oxidase. Biochem. Pharmacol., 14, 1684-1686 (1965) https://doi.org/10.1016/0006-2952(65)90025-0
- Lee, M. K., Hwang, B. Y., Lee, S. A., Oh, G. J., Choi, W. H., Hong, S. S., Lee, K. S., and Ro, J. S., 1-Methyl-2-undecyl- 4(1H)-quinolone as an irreversible and selective inhibitor of type B monoamine oxidase. Chem. Pharm. Bull., 51, 409-411 (2003) https://doi.org/10.1248/cpb.51.409
- Lee, S., Kim, K. S, Shim, S. H., Park, Y. M., and Kim, B. K. Constituents from the non-polar fraction of Artemisia apiacea. Arch. Pharm. Res., 26, 902-905 (2003) https://doi.org/10.1007/BF02980197
- Naoi, M. and Nagatsu, T., Quinoline and quininaldines as naturally occurring inhibitors specific for type A monoamine oxidase. Life Sci., 40, 1075-1082 (1987) https://doi.org/10.1016/0024-3205(87)90570-4
- Park, J. A., Kim, H. J., Jin, C., Lee, K. T., and Lee, Y. S., A new pterocarpan, (-)-maackiain sulfate, from the roots of Sophora subprostrata. Arch. Pharm. Res., 26, 1009-1013 (2003) https://doi.org/10.1007/BF02994750
- Ro, J. S., Lee, S. S., Lee, K. S., and Lee, M. K., Inhibition of type A monoamine oxidase by coptisine in mouse brain. Life Sci., 70, 639-645 (2001) https://doi.org/10.1016/S0024-3205(01)01437-0
- Ryu, S. Y., Lee, H. S., Kim, Y. K., and Kim, S. H., Determination of Isoprenyl and lavandulyl positions of flavonoids from Sophora flavescens by NMR experiment. Arch. Pharm. Res., 20, 491-495 (1997) https://doi.org/10.1007/BF02973946
- Sekine, T., Saito, K., Minami, R., Arai, N., Suzuki, H., Koike, Y., and Murakoshi, I., A new lupin alkaloid, (-)-leontalbinine Noxide, in Sophora flavescens var. angustifolia seeds and its synthesis by biomimetic transformation from (+)-matrine Noxide. Yakugaku Zasshi, 113, 53-62 (1993) https://doi.org/10.1248/yakushi1947.113.1_53
- Shih, J. C., Chen, K., and Ridd, M. J., Monoamine oxidase: from genes to behavior. Annu. Rev. Neurosci., 22, 197-217 (1999) https://doi.org/10.1146/annurev.neuro.22.1.197
- Suzuki, O., Katsumata, Y., Oya, M., Chari, V. M., Vermes, B., Wagner, H., and Hostettmann, K., Inhibition of type A and type B monoamine oxidases by naturally occurring xanthones. Planta Med., 42, 17-21 (1981) https://doi.org/10.1055/s-2007-971540
- Tang, W. and Eisenbrand, G., Chinese drugs of plant origin. Springer-Verlag, New York, pp. 931-943 (1992)
- Thomas, T., Monoamine oxidase-B inhibitors in the treatment of Alzheimer's disease. Neurobiol. Aging, 21, 343-348 (2000) https://doi.org/10.1016/S0197-4580(00)00100-7
- Thull, U., Kneubuhler, S., Testa, B., Borges, M. F. M., and Pinto, M. M. M., Substituted xanthones as selective and reversible monoamine oxidase A inhibitors. Pharm. Res., 10, 1187-1190 (1993) https://doi.org/10.1023/A:1018924503552
- Wu, L, J., Miyase, T., Ueno, A., Kuroyamagi, M., Noro, T., and Fukushima, S., Studies on the constituents of Sophora flavescens III. Yakugaku Zasshi, 105, 736-741 (1985) https://doi.org/10.1248/yakushi1947.105.8_736
- Yamada, M. and Yasuhara, H., Clinical pharmacology of MAO inhibitors: Safety and future. Nerurotoxicology, 25, 215-221 (2004) https://doi.org/10.1016/S0161-813X(03)00097-4